Search

everythinglearnresearchcommunity

for

Search:↓

High concentrations of rosemary and thyme extracts can damage thymus tissue and affect immune markers in chick embryos.

Dupilumab successfully treated a woman's alopecia areata and bullous pemphigoid, leading to full hair regrowth and symptom resolution.

Vitamin D receptor and hairless protein are essential for hair growth.

The patient's symptoms improved with treatment but recurred when the steroid dose was reduced, requiring ongoing therapy.

Adult mice with CBS deficiency show minimal health issues and normal lifespan despite high homocysteine levels.

A person was born with both a rare hairless condition and a type of birthmark, which is an uncommon combination.

NSG mice had the most mites, and genetic factors affect immune response and susceptibility.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

Mice with extra human KLK14 had hair and skin problems, including weaker cell bonds and inflammation, linked to Netherton syndrome.

Early diagnosis and treatment of Kaposi varicelliform eruption are crucial to prevent severe complications.

Omalizumab may cause temporary hair loss, especially in women aged 18-60.

Certain immune markers and vitamin levels could help diagnose alopecia areata.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

Human skin cells have a high-affinity system for biotin transport, crucial for skin health.

Sorafenib causes skin reactions by increasing the number and activity of skin mast cells.

Sex hormones likely don't affect atopic dermatitis in adolescents and adults.

Acne may signal underlying metabolic issues, and lifestyle changes can help manage both.

miRNA-based therapies show promise for treating skin diseases, including hair loss, in animals.

Nanocarriers can make acne treatments more effective and gentle on the skin.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Understanding T cells and signaling pathways can lead to better treatments for hair loss.

Human mesenchymal stem cells show promise for treating skin diseases, but more research is needed to improve treatments.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

Probiotics may help treat skin conditions like acne and eczema safely.

International guidelines for treating alopecia areata vary, focusing on different treatment options and related health issues.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Bioprinting is improving skin models for better testing of skin diseases without using animals.